Saudi Arabia Clinical Nutrition Market to Grow at 10.3% until 2028
Published | 27 July 2022
Saudi Arabia Clinical Nutrition Market is flourishing owing to the growing elderly population, increased birth rate, rising number of malnutrition patients seeking care, and rising number of preterm births…
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the Saudi Arabia Clinical Nutrition Market is predicted to grow at a CAGR of 10.3% during the forecast period i.e. 2022 - 2028. The Saudi Arabia Clinical Nutrition Market is booming because of the rise of the middle class in emerging economies, rising healthcare spending, and an increase in the prevalence of metabolic illnesses are all factors advancing the clinical nutrition sector. Market growth is anticipated to be fueled by the growing elderly population as well as the creation of therapeutic nutrition products designed for the aging population. Also, malnutrition, respiratory illnesses, gastrointestinal disorders, cancer, and cardiovascular issues are a few of the chronic diseases whose incidence is rising among children and adults. Furthermore, Saudi Arabia Clinical Nutrition Market is one of the most emerging markets that grow continuously owing to the fast integration of new technologies such as the Internet of Things (IoT), Artificial Intelligence (AI), cloud computing, and others. However, several barriers may prevent the adoption of alternative forms of nutrition, including a lack of information, particularly in developing regions, and strict government controls. The refusal of reasonable means to ingest nourishment and the lack of acceptance of novel approaches can both be ascribed to poorer living standards in the least developed parts of the world, which can have an impact on the growth of the clinical nutrition market.
Growing Numbers of Senior Citizens
The market for clinical nutrition is expected to expand significantly in the next years as a result of the large rise in the number of elderly people and the increasing prevalence of chronic diseases like cancer and diabetes. In many locations, the elderly population is growing, making them more susceptible to chronic illnesses that necessitate clinical nutrition products during hospitalization and home care. This has gotten worse as a result of COVID-19's effects. Elderly persons frequently have digestive problems or loss of appetite, which calls for enteral or parenteral vitamin supplementation. It is projected that this skill would benefit the clinical nutrition industry globally throughout the upcoming years.
Healthcare Infrastructure Upgrades
In highly industrialized regions with a high frequency of chronic illnesses, the healthcare infrastructure that uses clinical nutrition is becoming more sophisticated. Additionally, innovation in targeted solutions and customization helps the industry expand. Medical nutrition is becoming more individualized, just as it is in other areas of health and wellness, thanks to developments like formulae that are more specifically formulated for certain conditions (including Crohn's disease, Alzheimer's disease, and post-surgery rehabilitation).
Request for Sample Report @ https://www.blueweaveconsulting.com/report/saudi-arabia-clinical-nutrition-market/report-sample
Challenge: Side Effects of Overdose
lack of awareness among certain segments of the country's population may pose a significant threat to overall market growth during the forecast period. Several nutritional supplements contain active ingredients that have significant side effects on the body. Patients are more likely to experience side effects from dietary supplements if they are taken in high doses, instead of prescribed medications, or in combination with other supplements. Some supplements may increase your risk of bleeding or, if taken before surgery, may alter your response to anesthesia. Supplements can also interact with some medications, potentially causing serious problems in the human body. As a result, the high risk of side effects and the high cost of nutritional supplements act as a barrier to market growth.
Saudi Arabia Clinical Nutrition Market - By Substrate
Based on substrate, the Saudi Arabia Clinical Nutrition Market is segmented into Energy, Carbohydrates, Lipids, Protein, Amino Acids, Water & Electrolyte, Dietary Fibre, and Antioxidants. Among these, the protein segment dominates the market. Not just in the fitness world, protein is experiencing a moment. But there's a good reason for all the hoopla. For healthy health, protein is necessary. The building blocks of the body are provided by protein, and not simply by muscle. Protein is found in every cell, including the skin, hair, and bones. Protein makes up all of the human hormones, antibodies, and other vital components. The body only uses protein as fuel when it is necessary. Additionally, different amino acids make up proteins. Some amino acids can be produced by the body on their own, while many essential amino acids can only be obtained through diet. The human body needs a range of amino acids to operate effectively.
Impact of COVID-19 on Saudi Arabia Clinical Nutrition Market
The therapeutic nutrition market has been impacted by the ongoing COVID-19 pandemic and the country-wide lockdowns that have been implemented. However, as individuals with COVID-19 typically need dietary supplements for a variety of micro and macronutrients, the necessity for nutritional therapy has grown. According to a study, the significance of proper nutrition and diet during the COVID-19 pandemic has also been extensively discussed, not only as a way to stop the development of noncommunicable illnesses but also as a way to control the inflammatory status of the patients. Furthermore, failing to recognize the importance of diet in COVID-19 may have a serious impact on the patient's prognosis. With dietary supplements made specifically for each patient's ailment, hospitals and clinics may now better serve their needs. These developments are projected to boost industry statistics throughout the anticipated year by increasing clinical nutrition management patient usage.
The leading market players in the Saudi Arabia Clinical Nutrition Market are Nestle Saudi Arabia LLC, Abbott Saudi Arabia, Fresenius Medical Care Saudi Arabia Limited, Ideal Nutrition, Almarai Company, B Braun Saudi Arabia, BASF Saudi Arabia, and other prominent players. The Saudi Arabia Clinical Nutrition Market is highly fragmented with the presence of several manufacturing companies in the country. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Saudi Arabia Clinical Nutrition Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Saudi Arabia Clinical Nutrition Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
Recent Press Releases
- Saudi Arabia Disposable Mask Market Witnessing Sturdy Growth — Projected to Grow at a CAGR of 17.5% During 2022-2028
- Global Eyewear Market to Remain Prolific—Projected to Reach worth USD 177.1 Billion in 2027
- Global Collagen Peptides Market to Witness Steady Growth and Reach USD 4,778.40 Million by 2026
- Laser Therapy Market is Expected to Reach USD XX Million By 2027
- United States Healthcare Asset Management Market to Grow at a CAGR of 36.2% until 2028
- Global ELISpot and FluoroSpot Assays Market Gaining Momentum: Projected to Touch USD 605.4 Million By 2027, Growing at the CAGR of 20.6% during the Forecast Period